04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The National Labor Relations Board just relaxed its test for determining the legality of an employer...
Read More >
In February 2012, an Invenergy affiliate named California Ridge Wind Energy LLC (“California Ridge”...
Read More >
Despite global economic uncertainty, M&A activity is expected to accelerate in the years to come. Ac...
Read More >
As a result of the “stop work order” on construction in New York State, many projects are now bein...
Read More >
The Supreme Court in the UK, the highest court in the country, last week ruled on a restrictive cove...
Read More >
On December 19, 2020, China's National Development and Reform Commission ("NDRC") and the Ministry o...
Read More >